• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用循环微RNA表达谱灵敏检测黑色素瘤转移

Sensitive detection of melanoma metastasis using circulating microRNA expression profiles.

作者信息

Shiiyama Rie, Fukushima Satoshi, Jinnin Masatoshi, Yamashita Junji, Miyashita Azusa, Nakahara Satoshi, Kogi Ai, Aoi Jun, Masuguchi Shinichi, Inoue Yuji, Ihn Hironobu

机构信息

Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

出版信息

Melanoma Res. 2013 Oct;23(5):366-72. doi: 10.1097/CMR.0b013e328363e485.

DOI:10.1097/CMR.0b013e328363e485
PMID:23863473
Abstract

Numerous studies have indicated that the serum levels of microRNAs are useful for the diagnosis or evaluation of activity in human diseases. However, determining the level of only one of the nearly 2000 microRNAs identified so far may be less significant. Accordingly, we examined the possibility that the expression pattern of multiple microRNAs in each patient may be a more reliable disease marker for melanoma, especially metastatic disease, focusing on the interaction among microRNAs. Six microRNAs (miR-9, miR-145, miR-150, miR-155, miR-203, and miR-205) were evaluated using real-time PCR in 11 patients with metastatic melanoma and in 16 patients without melanoma. The expression of the six microRNAs was significantly different between the patients with metastasis and those without it. MiR-9 and miR-205 and miR-203 and miR-205 showed significant correlations, and the combination of miR-9, miR-145, miR-150, miR-155, and miR-205 was more sensitive than when each miR was used individually to distinguish the patients with metastasis from those without it. This is the first report demonstrating the expression profiles of multiple microRNAs in melanoma patients. Clarifying the involvement of the microRNA network in the pathogenesis of melanoma may contribute to the development of new diagnostic tools and to advancing the understanding of this disease.

摘要

众多研究表明,微小RNA的血清水平可用于人类疾病的诊断或活动评估。然而,仅测定目前已鉴定出的近2000种微小RNA中的一种的水平,可能意义不大。因此,我们研究了每个患者中多种微小RNA的表达模式可能是黑色素瘤尤其是转移性疾病更可靠的疾病标志物的可能性,重点关注微小RNA之间的相互作用。使用实时聚合酶链反应对11例转移性黑色素瘤患者和16例无黑色素瘤患者的六种微小RNA(miR-9、miR-145、miR-150、miR-155、miR-203和miR-205)进行了评估。有转移的患者和无转移的患者之间六种微小RNA的表达存在显著差异。miR-9与miR-205以及miR-203与miR-205之间显示出显著相关性,并且miR-9、miR-145、miR-150、miR-155和miR-205的组合比单独使用每种miR区分有转移的患者和无转移的患者更敏感。这是第一份证明黑色素瘤患者中多种微小RNA表达谱的报告。阐明微小RNA网络在黑色素瘤发病机制中的作用可能有助于开发新的诊断工具,并增进对这种疾病的了解。

相似文献

1
Sensitive detection of melanoma metastasis using circulating microRNA expression profiles.利用循环微RNA表达谱灵敏检测黑色素瘤转移
Melanoma Res. 2013 Oct;23(5):366-72. doi: 10.1097/CMR.0b013e328363e485.
2
Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.鉴定循环微小RNA谱作为转移性皮肤黑色素瘤的生物标志物
Acta Derm Venereol. 2016 Jan;96(1):29-34. doi: 10.2340/00015555-2156.
3
Decreased serum microRNA-206 level predicts unfavorable prognosis in patients with melanoma.血清微小RNA-206水平降低预示黑色素瘤患者预后不良。
Int J Clin Exp Pathol. 2015 Mar 1;8(3):3097-103. eCollection 2015.
4
Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma.鉴定血浆微小RNA作为人类皮肤黑色素瘤具有高诊断效能的新型潜在生物标志物。
Tumour Biol. 2017 May;39(5):1010428317701646. doi: 10.1177/1010428317701646.
5
The Potential of Circulating miR-193b, miR-146b-3p and miR-483-3p as Noninvasive Biomarkers in Cutaneous Melanoma Patients.循环 miR-193b、miR-146b-3p 和 miR-483-3p 作为非侵入性生物标志物在皮肤黑色素瘤患者中的潜力。
Mol Biotechnol. 2024 Oct;66(10):2830-2840. doi: 10.1007/s12033-023-00893-x. Epub 2023 Nov 7.
6
Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.原发性皮肤恶性黑色素瘤、皮肤恶性黑色素瘤转移灶和良性黑色素痣的 microRNA 表达谱的比较微阵列分析。
Cell Tissue Res. 2013 Jan;351(1):85-98. doi: 10.1007/s00441-012-1514-5. Epub 2012 Oct 31.
7
A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients.对缺氧状态下循环微RNA - 210进行直接血浆检测可识别黑色素瘤患者早期全身转移复发情况。
Oncotarget. 2015 Mar 30;6(9):7053-64. doi: 10.18632/oncotarget.3142.
8
Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.miR-203的表达降低,且与黑色素瘤患者的预后相关。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):13249-54. eCollection 2015.
9
Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients.人 miR-1228 作为一种稳定的内源性对照,用于定量检测癌症患者循环中的 microRNAs。
Int J Cancer. 2014 Sep 1;135(5):1187-94. doi: 10.1002/ijc.28757. Epub 2014 Mar 10.
10
Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.血浆循环 microRNA-944 和 microRNA-3662 作为潜在的组织学类型特异性早期肺癌生物标志物。
Transl Res. 2015 Oct;166(4):315-23. doi: 10.1016/j.trsl.2015.05.009. Epub 2015 May 29.

引用本文的文献

1
A New Approach to Melanoma Treatment: microRNAs.一种新的黑素瘤治疗方法:microRNAs。
Curr Top Med Chem. 2024;24(16):1362-1376. doi: 10.2174/0115680266291290240417081544.
2
Unlocking melanoma Suppression: Insights from Plasma-Induced potent miRNAs through PI3K-AKT-ZEB1 axis.解锁黑色素瘤抑制作用:通过PI3K-AKT-ZEB1轴从血浆诱导的强效miRNA中获得的见解。
J Adv Res. 2025 Feb;68:147-161. doi: 10.1016/j.jare.2024.02.022. Epub 2024 Mar 4.
3
Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis.
循环 microRNAs 作为黑色素瘤的诊断生物标志物:系统评价和荟萃分析。
BMC Cancer. 2023 May 8;23(1):414. doi: 10.1186/s12885-023-10891-6.
4
Exosome-Derived microRNA: Implications in Melanoma Progression, Diagnosis and Treatment.外泌体衍生的微小RNA:在黑色素瘤进展、诊断和治疗中的意义
Cancers (Basel). 2022 Dec 23;15(1):80. doi: 10.3390/cancers15010080.
5
Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype.循环无细胞信使 RNA 使黑色素瘤治疗的非侵入性泛肿瘤监测成为可能,而与突变基因型无关。
Clin Transl Med. 2022 Nov;12(11):e1090. doi: 10.1002/ctm2.1090.
6
The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies.微小RNA在液体活检中作为诊断和预后生物标志物的作用。
Cancer Drug Resist. 2020 Feb 21;3(2):117-139. doi: 10.20517/cdr.2019.103. eCollection 2020.
7
Current Trends in Circulating Biomarkers for Melanoma Detection.黑色素瘤检测中循环生物标志物的当前趋势
Front Med (Lausanne). 2022 Apr 5;9:873728. doi: 10.3389/fmed.2022.873728. eCollection 2022.
8
Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives.液体活检的最新进展及其未来展望:有望成为黑色素瘤的血液生物标志物。
Curr Treat Options Oncol. 2022 Apr;23(4):562-577. doi: 10.1007/s11864-022-00948-2. Epub 2022 Mar 17.
9
Revisiting miRNA Association with Melanoma Recurrence and Metastasis from a Machine Learning Point of View.从机器学习角度重新探讨 miRNA 与黑色素瘤复发和转移的关系。
Int J Mol Sci. 2022 Jan 24;23(3):1299. doi: 10.3390/ijms23031299.
10
MicroRNA-9 as a paradoxical but critical regulator of cancer metastasis: Implications in personalized medicine.微小RNA-9作为癌症转移的矛盾但关键的调节因子:在个性化医疗中的意义
Genes Dis. 2020 Oct 23;8(6):759-768. doi: 10.1016/j.gendis.2020.10.005. eCollection 2021 Nov.